Magnetic hyperthermia therapy enhances the chemoradiosensitivity of glioblastoma

Magnetic hyperthermia therapy enhances the chemoradiosensitivity of glioblastoma

Abstract Glioblastoma (GBM) is the most common primary brain cancer and is resistant to standard-of-care chemoradiation therapy (CRT). Magnetic hyperthermia therapy (MHT) exposes magnetic iron oxide nanoparticles (MIONPs) to an alternating magnetic field (AMF) to generate local hyperthermia. This st...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Rivera, Alexandros Bouras, Milena Mattioli, Maria Anastasiadou, Anna Chiara Pacentra, Olivia Pelcher, Corrine Koziel, Alexander J. Schupper, Tori Chanenchuk, Hayden Carlton, Robert Ivkov, Constantinos G. Hadjipanayis
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Glioblastoma
Magnetic hyperthermia therapy
Magnetic iron-oxide nanoparticles
Radiation therapy
Temozolomide
Chemoradiation
Online Access:https://doi.org/10.1038/s41598-025-95544-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-95544-3

Similar Items